News | May 14, 2022
CCMB develops India’s first mRNA vaccine technology
The mRNA vaccine candidate is fully indigenous and devoid of any technology contributions from elsewhere
The mRNA vaccine candidate is fully indigenous and devoid of any technology contributions from elsewhere
Nirsevimab is the first investigational immunization designed to protect all infants across the RSV season with a single dose
CEPI will provide funding of up to US $19.3 million to support the development of a ‘variant-proof’ SARS-CoV-2 vaccine candidate to an international multidisciplinary consortium
Aims to increase compliance and improve outcomes for People with Diabetes (PwD)
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
The aim is to bring patient consent tools in a digital format in addition to a paper format which is not just a need of the current times but also a way forward
He will be responsible for ensuring that every dose of medication that ACG Inspection’s pharmaceutical and nutraceutical partners provide is manufactured and delivered exactly as intended
This agreement is truly remarkable for achieving greater objectives in the projects and addressing larger problems
Formula attenuates 99% of 365 coronaviruses in computer models
Avacc 3 has significant advantages over existing whooping cough vaccines
Subscribe To Our Newsletter & Stay Updated
